SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Amira Pharmaceuticals, Inc. Announces the Nomination of an Orally Available Pre-Clinical Candidate in a New LPA-Related Program, an Autotaxin Inhibitor